These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 7221048)

  • 1. [Clinical dosimetry in radium 226 and iridium 192 interstitial therapy of oral tongue cancer (author's transl)].
    Baroncelli G; Feroldi P; Frata P
    Radiol Med; 1980 Nov; 66(11):819-26. PubMed ID: 7221048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of intra-oral carcinoma by iridium-192 wire interstitial brachytherapy--compared with results by radium needles (author's transl)].
    Ikeda H; Inoue T; Miyata Y; Ozeki S; Hayami A; Tanaka Y; Wada T; Fuchihata H; Masaki N; Shigematsu Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Jan; 38(1):23-7. PubMed ID: 634753
    [No Abstract]   [Full Text] [Related]  

  • 3. [Computerised dosimetry in interstitial management with 192Ir sources (author's transl)].
    Feroldi P; Gallini R; Verzeletti L
    Radiol Med; 1977 Jun; 63(6):539-44. PubMed ID: 601251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radiotherapy of epidermoid cancers of the mobile tongue (study of 280 cases with a comparison between radium and iridium 192)].
    Pierquin B; Chassagne D; Baillet F; Cachin Y; Richard J; Fournelle le Buis F
    Presse Med (1893); 1968 Nov; 76(44):2097-8. PubMed ID: 5701037
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary combined radiotherapy of carcinoma of the uterine cervix. Comparison of 192Ir with radium].
    Schmieder A; Jacobs H
    Strahlentherapie; 1985 May; 161(5):270-4. PubMed ID: 3923662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Present status of brachytherapy].
    Hahimoto S; Dokiya T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):885-93. PubMed ID: 3963855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical evaluation of a total dose-dose rate relationship in oral tongue cancer 192 Ir implants.
    Feroldi P; Frata P; Baroncelli G; Belletti S
    Strahlenther Onkol; 1986 Sep; 162(9):561-4. PubMed ID: 3764680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NSD and the 192Ir management of skin cancer (author's transl)].
    Sinistrero G; Ferraris R
    Radiol Med; 1977 Feb; 63(2):135-7. PubMed ID: 877308
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the long-term results of brachytherapy for T1-2N0 oral tongue cancer treated with Ir-192 and Ra-226.
    Yamazaki H; Inoue T; Koizumi M; Yoshida K; Kagawa K; Shiomi H; Nose T; Tanaka E; Teshima T; Nakamura H; Shimizutani K; Furukawa S; Fuchihata H; Inoue T
    Anticancer Res; 1997; 17(4A):2819-22. PubMed ID: 9252722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongue implants: discussion of some dose-time-volume parameters and afterloading techniques.
    Burgers JM
    Radiol Clin (Basel); 1978; 47(3):204-14. PubMed ID: 663089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Restriction of indications and first results with the high-dose rate-afterloading technic (iridium-192)].
    Kucera H; Weghaupt K
    Strahlentherapie; 1984 Aug; 160(8):469-73. PubMed ID: 6474520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brachytherapy of cancer].
    Nishio M; Sakurai T; Kagami Y; Narimatsu N
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1519-30. PubMed ID: 3592698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interstitial curietherapy with iridium 192 applied to small cancers of the rectum (author's transl)].
    Papillon J; Montbarbon JF; Gérard JP
    J Radiol Electrol Med Nucl; 1975 May; 56(5):439-42. PubMed ID: 1177190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iridium curietherapy in conservative treatment of infiltrating cancer of the bladder].
    Gérard JP; De Laroche G; Ardiet JM; Romestaing P; Auque JR
    J Urol (Paris); 1985; 91(3):139-44. PubMed ID: 4045208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of interstitial curietherapy in T3 and T4 floor of the mouth and tongue cancers after previous arterial infusion chemotherapy.
    Chassagne D; Richard JM; Le Floch O
    Panminerva Med; 1976; 18(1-2):45-9. PubMed ID: 1246449
    [No Abstract]   [Full Text] [Related]  

  • 16. [Afterloading interstitial brachytherapy by Ir-192 seed assembly for malignant brain tumor].
    Nishio M; Sakurai T; Kagami Y; Murakami Y; Hareyama M; Saito A; Hotta T; Shimada T; Kamata H; Wada K
    Gan No Rinsho; 1984 Jun; 30(7):757-64. PubMed ID: 6086977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of interstitial curietherapy and combined transcutaneous radiotherapy-curietherapy in 150 patients with carcinoma of the tongue and/or mouth floor].
    Sannazzari GL; Negri GL; Ozzello F; Gabriele P; Orecchia R; Ragona R
    Radiol Med; 1986; 72(1-2):37-42. PubMed ID: 3961214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue.
    Inoue T; Inoue T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169
    [No Abstract]   [Full Text] [Related]  

  • 19. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.
    Bourgier C; Coche-Déquéant B; Fournier C; Castelain B; Prévost B; Lefebvre JL; Lartigau E
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):434-40. PubMed ID: 16168836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Time factor and curietherapy: the example of epidermoid carcinoma of the mobile tongue].
    Mazeron JJ; Mornex F
    Bull Cancer Radiother; 1990; 77(1):15-22. PubMed ID: 8703538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.